.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Fuji
McKinsey
McKesson
Harvard Business School
US Army
Baxter
Federal Trade Commission
Colorcon
Fish and Richardson

Generated: November 24, 2017

DrugPatentWatch Database Preview

Entecavir - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for entecavir and what is the scope of entecavir freedom to operate?

Entecavir
is the generic ingredient in two branded drugs marketed by Aurobindo Pharma Ltd, Teva Pharms Usa, Accord Hlthcare, Hetero Labs Ltd V, Zydus Pharms Usa Inc, Amneal Pharms, Cipla Ltd, Sandoz Inc, Prinston Inc, Par Pharm Inc, and Bristol Myers Squibb, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for entecavir. Fourteen suppliers are listed for this compound.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
BARACLUDE
entecavir
TABLET;ORAL021797-002Mar 29, 2005ABRXYesYes► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
ENTECAVIR
entecavir
TABLET;ORAL205740-001Aug 21, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
ENTECAVIR
entecavir
TABLET;ORAL206745-002Jun 23, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
ENTECAVIR
entecavir
TABLET;ORAL206652-001Nov 12, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Cipla Ltd
ENTECAVIR
entecavir
TABLET;ORAL206872-001Dec 6, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ENTECAVIR
entecavir
TABLET;ORAL202122-001Aug 26, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm Inc
ENTECAVIR
entecavir
TABLET;ORAL206294-002Nov 23, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
BARACLUDE
entecavir
TABLET;ORAL021797-001Mar 29, 2005ABRXYesNo► Subscribe► Subscribe► Subscribe
Sandoz Inc
ENTECAVIR
entecavir
TABLET;ORAL206672-002May 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Accord Hlthcare
ENTECAVIR
entecavir
TABLET;ORAL205824-001Aug 25, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: entecavir

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb
BARACLUDE
entecavir
TABLET;ORAL021797-001Mar 29, 2005► Subscribe► Subscribe
Bristol Myers Squibb
BARACLUDE
entecavir
SOLUTION;ORAL021798-001Mar 29, 2005► Subscribe► Subscribe
Bristol Myers Squibb
BARACLUDE
entecavir
SOLUTION;ORAL021798-001Mar 29, 2005► Subscribe► Subscribe
Bristol Myers Squibb
BARACLUDE
entecavir
TABLET;ORAL021797-002Mar 29, 2005► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Citi
Chubb
Baxter
US Department of Justice
Covington
Johnson and Johnson
McKesson
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot